Review of PET’s ‘Breast Cancer, Business and Patents’: Ensuring your genes don’t affect your insurance

I tried to make insurance interesting on behalf of the Progress Educational Trust (PET) and the Wellcome Trust. Have a read.

The piece comes from PET’s recent event ‘Risk Management: Breast Cancer, Business and Patents’ — the third of their four-part project ‘Breast Cancer: Chances, Choices and Genetics’.

Simon Hazelwood-Smith reviewed the night for BioNews.

James Heather covered the second event — Risk Assessment: Breast Cancer, Prediction and Screening.

I covered the first one for BioNews and James wrote it up for the Wellcome Trust blog.

The final event — Breast Cancer Risk: Facts, Fictions and the Future — is taking place on Thursday 3rd July. See PET’s website for more details.

Relative Risk: Breast Cancer and Genetics — Review for the Progress Educational Trust

Last week, the Progress Education Trust launched a new project called ‘Breast Cancer: Chances, Choices and Genetics’, inspired by Angelina Jolie’s risk-reducing mastectomy surgery. It’s a topic I was previously keen on avoiding. I hoped to get through an entire science-writing career without using the ‘C’ word, but alas. I’ve reviewed the first of the four events for BioNews (have a read then come back here).

By dint of deadlines and word counts, I had to leave out so much I wanted to say about the evening. The rest of this post contains a hodgepodge of offcuts from my review.
Continue reading